Reinhard Hohlfeld Selected Research

Myelin Basic Protein

1/2018

Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reinhard Hohlfeld Research Topics

Disease

88	Multiple Sclerosis 04/2022 - 01/2002
10	Relapsing-Remitting Multiple Sclerosis 01/2018 - 09/2007
8	Progressive Multifocal Leukoencephalopathy 01/2019 - 11/2005
6	Inflammation (Inflammations) 01/2021 - 06/2004
6	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 11/2008
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 03/2003
6	Autoimmune Diseases (Autoimmune Disease) 12/2016 - 11/2005
5	Neuromyelitis Optica (Devic's Disease) 01/2018 - 04/2007
5	Polymyositis 06/2012 - 07/2002
4	Neoplasms (Cancer) 01/2021 - 05/2009
4	Central Nervous System Diseases (CNS Diseases) 12/2017 - 08/2004
4	Myositis (Idiopathic Inflammatory Myopathies) 03/2016 - 05/2003
4	Necrosis 06/2004 - 01/2002
3	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2018
3	Autoimmune Diseases of the Nervous System 01/2021 - 01/2010
3	Neuroinflammatory Diseases 07/2019 - 10/2014
3	Encephalomyelitis (Myeloencephalitis) 01/2018 - 08/2004
3	Infections 12/2016 - 08/2005
3	Inclusion Body Myositis 06/2012 - 09/2003
3	Rhabdomyosarcoma 05/2003 - 07/2002
2	Optic Neuritis (Retrobulbar Neuritis) 07/2019 - 04/2008
2	Atrophy 01/2019 - 09/2015
2	Disease Progression 01/2019 - 10/2007
2	Melanoma (Melanoma, Malignant) 08/2016 - 02/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2015 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011 - 03/2003
2	Thymoma (Thymic Carcinoma) 09/2008 - 07/2008
2	Transverse Myelitis (Necrotizing Myelitis) 04/2008 - 04/2007
1	Fatigue 01/2021
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 11/2020
1	Psychotic Disorders (Schizoaffective Disorder) 11/2020
1	Ganglion Cysts (Ganglion) 07/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Multiple Myeloma 01/2017
1	Leukopenia 12/2016
1	Thyroid Diseases (Thyroid Disease) 12/2016

Drug/Important Bio-Agent (IBA)

16	AntigensIBA 12/2016 - 01/2002
15	AntibodiesIBA 01/2021 - 04/2007
12	AutoantibodiesIBA 01/2021 - 11/2008
11	Natalizumab (Tysabri)FDA Link 01/2016 - 11/2005
10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 01/2002
10	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 02/2010
10	Glatiramer Acetate (Copaxone)FDA Link 05/2014 - 11/2002
8	Myelin-Oligodendrocyte GlycoproteinIBA 07/2019 - 05/2009
8	Immunoglobulin G (IgG)IBA 07/2019 - 08/2005
7	Oligoclonal BandsIBA 12/2016 - 06/2008
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
5	Monoclonal AntibodiesIBA 01/2019 - 01/2002
5	EnzymesIBA 10/2014 - 11/2002
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2008 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2006
4	Peptides (Polypeptides)IBA 01/2019 - 01/2002
4	Sphingosine-1-Phosphate ReceptorsIBA 09/2015 - 02/2011
4	Immunoglobulins (Immunoglobulin)IBA 04/2011 - 08/2005
3	Pharmaceutical PreparationsIBA 12/2016 - 11/2005
3	Alemtuzumab (Campath)FDA Link 12/2016 - 11/2012
3	Neuroprotective AgentsIBA 09/2015 - 01/2002
3	N-acetyltalosaminuronic acid (NAT)IBA 11/2014 - 09/2011
3	MicroRNAs (MicroRNA)IBA 09/2012 - 12/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2004 - 01/2002
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2003 - 01/2002
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2020
2	InterferonsIBA 01/2019 - 05/2014
2	Immune Checkpoint InhibitorsIBA 01/2019 - 12/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019 - 01/2002
2	ocrelizumabIBA 01/2018 - 01/2017
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2017 - 06/2015
2	LigandsIBA 01/2015 - 01/2002
2	Aquaporin 4IBA 07/2011 - 04/2007
2	Cladribine FDA LinkGeneric 07/2011 - 01/2002
2	CytokinesIBA 05/2011 - 01/2002
2	ProteomeIBA 04/2011 - 06/2008
2	Nerve Growth Factors (Neurotrophins)IBA 02/2008 - 04/2006
2	Complement System Proteins (Complement)IBA 10/2007 - 09/2003
2	Intravenous Immunoglobulins (IVIG)FDA Link 05/2007 - 01/2002
1	AutoantigensIBA 04/2022
1	BNT162 VaccineIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	ponesimodIBA 01/2021
1	teriflunomideIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 07/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2019
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019
1	Myelin Basic ProteinIBA 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Daclizumab (Zenapax)FDA Link 12/2016
1	Transaminases (Aminotransferases)IBA 12/2016
1	IpilimumabIBA 08/2016
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 09/2015

Therapy/Procedure

31	Therapeutics 01/2022 - 01/2002
3	Lasers (Laser) 09/2011 - 04/2003
2	Immunotherapy 12/2017 - 10/2004
2	Plasma Exchange 12/2012 - 11/2012